MetroHealth Medical Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, MetroHealth Medical Center sits in the top decile of US sponsors by registered trial count (#286 of 15,742 sponsors by registered trial count).
MetroHealth Medical Center: 76 sponsored US clinical trials, 10 recruiting.
MetroHealth Medical Center sponsors 76 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 53 completed. 7 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 5 trials.
Top-decile sponsor footprint
MetroHealth Medical Center ranks in the top decile of sponsors by registered trial count (#286 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
53 of 60 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
76 total, page 1 of 2
Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury
NCT06734026
At-Home Genital Nerve Stimulation for SCI Bowel
NCT06836739
Restoration of Hand Function in Cervical SCI
NCT06611748
Positive Peers Intervention Clinical Trial
NCT06388109
tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia
NCT05866003
Implant for Walking After Stroke
NCT05740540
Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury
NCT05626816
Feasibility of Early Gabapentin as an Intervention for Neurorecovery
NCT05302999
Grasp-Release Assessment of a Networked Neuroprosthesis Device
NCT05863754
Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation
NCT03857529
AutoSTEA for Adults With Functional Dyspepsia
NCT07020416
Family-Centered Treatment for Depression in Hispanic Youth
NCT05407051
Reflex Excitability in Post-stroke Stiff-Knee Gait
NCT04947865
Implanted Myoelectric Control for Restoration of Hand Function in Spinal Cord Injury
NCT00583804
AI-guided Prediction and Treatment of Cardiac Arrest
NCT07452016
The Improving Sleep in African American Couples Study (ISAAC)
NCT07447284
Gastric POCUS Clear Liquids
NCT07214909
Ambulatory Closed-loop Stimulation for Bladder Control
NCT05740527
The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections
NCT04479709
Cardio-pulmonary Rehabilitation and Sleep Quality
NCT04668599
Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery
NCT04233385
Registry and Screening Tool to Identify Children With Asthma Likely to Benefit From Home Assessment and Remediation
NCT03916237
Pain, Anxiety During Interventional Spine Procedures
NCT04257019
Targeted Breast Milk Fortification for Very Low Birth Weight Infants in the NICU
NCT04025021
Pudendal Nerve Block in Vaginal Surgery
NCT04198714
Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI
NCT04256603
ICE-T Pain Regimen for Total Laparoscopic Hysterectomy
NCT03987022
Peripheral Nerve Stimulation(PNS) for Subacromial Impingement Syndrome(SIS)
NCT03752619
Therapies for Recovery of Hand Function After Stroke
NCT03574623
Using Lay Health Advisors to Improve Hypertension Management
NCT03515005
Pain Medications Following Thyroidectomy and Parathyroidectomy
NCT03640247
Two Bag System for Diabetic Ketoacidosis
NCT03660189
Community Members as Reviewers of Medical Journal Manuscripts
NCT03432143
Identifying and Treating Depression in Hemodialysis Patients
NCT03390933
Mesenchymal Stem Cells in Early Rheumatoid Arthritis
NCT03186417
Impact of OSA on Outcomes in Acute Coronary Syndrome
NCT03793582
Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV
NCT03976258
Multimodal Treatment for Hemiplegic Shoulder Pain
NCT02893267
Contralaterally Controlled FES for Hand Opening in Hemiplegic Cerebral Palsy
NCT02925455
Peripheral Nerve Stimulation for Shoulder Pain: Dose Response
NCT02928055
Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
NCT03099863
Pulse Pressure and Post-epidural Fetal Heart Rate Changes
NCT02565485
Stimulation With Wire Leads to Restore Cough
NCT01659541
Massage for Post Breast Surgery
NCT02250898
Symptom Control Satisfaction With Proton Pump Inhibitor Regimen
NCT02623816
Role of Low Lactose Infant Formula In The Management of Neonatal Abstinence Syndrome
NCT03549936
Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke
NCT02199795
Contralaterally Controlled FES of Arm & Hand for Subacute Stroke Rehabilitation
NCT01688856
Oral Glucose Tolerance Testing After Gestational Diabetes
NCT02082301
Barriers to Peritoneal Dialysis Selection
NCT01517841
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 1 |
| Phase 4 | 7 |
Therapeutic Areas
What is open in the MetroHealth Medical Center pipeline
10 recruiting of 76 indexed (13% open); 53 completed (70%).
Phase mix: 7 late (III/IV) vs 7 early (I/II) (balanced across stages).
Top condition: Stroke (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
MetroHealth Medical Center: open-pipeline peers nationwide
Peers matched on 76 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
MetroHealth Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 76 trials (± recruiting share)
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
- Texas Tech University Health Sciences Center · 76 trials · 13% recruiting
- University of New Mexi · 76 trials · 30% recruiting
- University of Hawaii · 77 trials · 17% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · 13% recruiting · 523 trials
- Food and Drug Administration (FDA) · 13% recruiting · 23 trials
- Loyola University · 13% recruiting · 92 trials
- VA Greater Los Angeles Healthcare System · 13% recruiting · 23 trials
Related
What to do with this MetroHealth Medical Center page
76 registered trials is a research-attention snapshot, not an endorsement of MetroHealth Medical Center or any single study.
- 10 of MetroHealth Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition MetroHealth Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
MetroHealth Medical Center pipeline card: 76 registered trials from official public datasets.Report a data error.